Samsung Medical Center, Sungkyunkwan University School of Medicine
Seoul, Korea, Republic of
University hospital in South Korea
Gyeongsangnam-do, 창원시 마산회원구 Paryong-ro, 158 KR
About Samsung Medical Center, Sungkyunkwan University School of Medicine
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Samsung Medical Center
36
Hoffmann-La Roche
5
Pfizer
4
Asan Medical Center
3
Kangbuk Samsung Hospital
3
Seoul National University Hospital
3
Inha University Hospital
2
Daiichi Sankyo, Inc.
1
GemVax & Kael
1
Hallym University Medical Center
1
Hospital Universitario Getafe
1
Clinical Trials at Samsung Medical Center, Sungkyunkwan University School of Medicine
During the past decade, Samsung Medical Center, Sungkyunkwan University School of Medicine conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 5 clinical trials were completed, i.e. on
average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer
2005-09-01
2008-07-01
Unknown status
44
Study for Safety and Efficiency of Therapeutic Angiogenesis for Patients With Limb Ischemia by Transplantation of Human Cord Blood Mononuclear Cell
Unknown status
Randomized Comparison of Curved Cutter Stapler and Linear Stapler
2006-05-01
2006-11-01
Completed
An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
2010-01-01
2015-12-01
Completed
1,069
Exelon Patch and Combination With Memantine Comparative Trial
2008-12-01
2010-04-01
Completed
206
Efficacy of Cap-assisted Chromoendoscopy as a Screening Test for Colorectal Neoplasm Using Web-based Research Network
2010-04-01
2012-06-01
Completed
1,905
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Samsung Medical Center, Sungkyunkwan University School of Medicine" #1 sponsor was "Samsung Medical Center" with 36 trials, followed by "Hoffmann-La Roche" with 5 trials
sponsored, "Pfizer" with 4 trials sponsored, "Asan Medical Center" with 3 trials sponsored and "Kangbuk Samsung Hospital"
with 3 trials sponsored. Other sponsors include 13 different institutions and
companies that sponsored additional 20 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Samsung Medical Center, Sungkyunkwan University School of Medicine"
#1 collaborator was "Inje University" with 3 trials as a collaborator, "Keimyung University Dongsan Medical Center" with 2 trials as a collaborator, "Korea University Guro Hospital" with 2 trials as a collaborator, "Korean Cancer Study Group" with 2 trials as a collaborator and "Samsung Medical Center" with 2 trials as a collaborator. Other collaborators include 31 different institutions and companies that were
collaborators in the rest 39 trials.
Clinical Trials Conditions at Samsung Medical Center, Sungkyunkwan University School of Medicine
According to Clinical.Site data, the most researched conditions in "Samsung Medical Center, Sungkyunkwan University School of Medicine" are
"Atrial Fibrillation" (3 trials), "Interstitial Cystitis" (3 trials), "Non-small Cell Lung Cancer (NSCLC)" (3 trials), "Stroke" (3 trials) and "Benign Prostatic Hyperplasia (BPH)" (2 trials). Many other conditions were trialed in "Samsung Medical Center, Sungkyunkwan University School of Medicine" in a lesser frequency.
Clinical Trials Intervention Types at Samsung Medical Center, Sungkyunkwan University School of Medicine
Most popular intervention types in "Samsung Medical Center, Sungkyunkwan University School of Medicine" are "Drug" (34 trials), "Procedure" (8 trials), "Device" (6 trials), "Other" (6 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "Placebo" (4 trials), "Carboplatin" (3 trials), "AZD9291" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Samsung Medical Center, Sungkyunkwan University School of Medicine
The vast majority of trials in "Samsung Medical Center, Sungkyunkwan University School of Medicine" are
61 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Samsung Medical Center, Sungkyunkwan University School of Medicine
Currently, there are NaN active trials in "Samsung Medical Center, Sungkyunkwan University School of Medicine".
undefined are not yet recruiting,
10 are recruiting,
6 are Active, not recruiting,
and 3 are Enrolling by invitation.
In total, there were 30 completed trials in Samsung Medical Center, Sungkyunkwan University School of Medicine,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Samsung Medical Center, Sungkyunkwan University School of Medicine, 1 "Phase 1"
clinical trials were conducted, 13 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 11 trials that are defined as “Not Applicable".